CAS: 35135-67-2 - (11beta,16alpha)-6,6,9-trifluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate

Formule : C₂₄H₂₉F₃O₆

InChI : InChI=1/C24H29F3O6/c1-12-7-15-16-9-22(25,26)17-8-14(29)5-6-20(17,3)23(16,27)18(30)10-21(15,4)24(12,32)19(31)11-33-13(2)28/h5-6,8,12,15-16,18,30,32H,7,9-11H2,1-4H3/t12-,15+,16+,18+,20+,21+,23+,24+/m1/s1

Synonymes :

• (11b,16a)-21-(Acetyloxy)-6,6,9-trifluoro-11,17-dihydroxy-16-methyl-pregna-1,4-diene-3,20-dione
• (11b,16a)-6,6,9-Trifluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate
• 35135-67-2
• Cormethasone acetate
• Rs 3694R

[2-Oxo-2-[(9R,11S,14S,16R,17R)-6,6,9-Trifluoro-11,16-Dihydroxy-10,13,17-Trimethyl-3-Oxo-8,11,12,14,15,16-Hexahydro-7H-Cyclopenta[a]P henanthren-17-Yl]Ethyl] Acetate

CAS : 35135-67-2

The present invention is a pharmaceutical preparation comprising 2-oxo-2-[(9R,11S,14S,16R,17R)-6,6,9-trifluoro-11,16-dihydroxy-10,13,17-trimethyl-3-oxo-8,11,12,14,15,16-hexahydrocyclopenta[a]ph enanthrene-17-yl]ethanol acetate. The compound has been …

• Formule : C₂₄H₂₉F₃O₆
• Degré de pureté : Min. 95%
• Masse moléculaire : 470.48 g/mol